Inotrem

Biotechnology company specialized in the control of inflammatory syndromes such as septic shock. #LifeScience #Biotech #Healthcare #Santé #Sepsis

[Inotrem @Inotrem_biotech]

Inotrem announces positive results from the Phase IIa study of its lead compound, nangibotide (LR12), in the treatment of septic shock
https://t.co/svBmBjX76P

[Inotrem @Inotrem_biotech]

Martin Koch joins Inotrem as Chief Operating Officer
#septicshock #sepsis #Biotechnology #innovation #healthcare

[Inotrem @Inotrem_biotech]

Inotrem granted access to Priority Medicines scheme (PRIME) for its lead compound MOTREM in the treatment of septic shock

[France Biotech @FranceBiotech]

[J-2] La French Health Tech: des opportunités économiques et sociales à comprendre et à saisir

[France Biotech @FranceBiotech]

👏 La biotech française Inotrem décroche un accord de R&D avec le groupe suisse Roche https://t.co/Tt7GGXdYrl

[Labiotech.eu @Labiotech_eu]

Did you expect this #septicshock collab? @Inotrem_biotech and Roche testing the #blood. #biotech #experimental https://t.co/uxA0DzFE3L